Daniele Santini

Pubblicazioni

Titolo Pubblicato in Anno
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma JOURNAL OF CLINICAL ONCOLOGY 2020
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy FRONTIERS IN ONCOLOGY 2020
Coronavirus disease 2019 or lung cancer: what should we treat? JOURNAL OF THORACIC ONCOLOGY 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2020
Bone health in cancer: ESMO Clinical Practice Guidelines ANNALS OF ONCOLOGY 2020
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy JOURNAL OF CLINICAL MEDICINE 2020
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis CLINICAL COLORECTAL CANCER 2020
Facing SARS-CoV-2 outbreak in immunotherapy era FUTURE ONCOLOGY 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? CLINICAL MEDICINE INSIGHTS: ONCOLOGY 2020
Tumor mutational load, microsatellite instability and actionable mutations in metastatic colorectal cancer: Results from the TRIBE2 study JOURNAL OF CLINICAL ONCOLOGY 2020
Brief letter of a doctor to his psychologist in the COVID-19 outbreak era ESMO OPEN 2020
Response to cabozantinib in renal cell carcinoma with cardiac metastases ANTI-CANCER DRUGS 2020
Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion ESMO OPEN 2020
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest EUROPEAN JOURNAL OF CANCER 2020
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol BMJ OPEN 2020
Denosumab for cancer-related bone loss EXPERT OPINION ON BIOLOGICAL THERAPY 2020
Recent advances in desmoid tumor therapy CANCERS 2020
Steroid-refractory immune related hepatitis may hide viral re-activation FUTURE SCIENCE OA 2020
Prognostic and predictive factors in pancreatic cancer ONCOTARGET 2020
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer INTERNATIONAL JOURNAL OF CANCER 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma